Westlake Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WLK research report →
Range $66 – $92
Price Chart
About the company
Westlake Corporation operates as a global producer and supplier of petrochemicals, polymers, and a diverse range of building materials. Its business activities are structured into two main divisions: Performance and Essential Materials, and Housing and Infrastructure Products. The Performance and Essential Materials segment focuses on the manufacture and distribution of various chemical components, including polyethylene, styrene monomer, ethylene co-products, PVC, VCM, ethylene dichloride chlor-alkali, and related chlorinated derivatives.
- CEO
- Jean-Marc Gilson
- IPO
- 2004
- Employees
- 14,600
- HQ
- Houston, TX, US
AI snapshot
Six angles, distilled from the data.
WLK remains in a long downtrend, trading well below its 200-day average of 86.46 and far under its 52-week high of 122.63. The stock is still closer to the lower end of its yearly range, which keeps the regime defensive even after a recent bounce from the lows.
Street sentiment is cautious: the consensus sits at Hold, with 7 Buys, 20 Holds, and 5 Sells. The average target is about 79, but recent revisions have leaned lower, including cuts from Morgan Stanley, RBC, UBS, and Mizuho, while Barclays started at Underweight.
The setup is mixed after a miss on the latest quarter, with EPS of 0.45 versus 0.60 expected. Analysts still model a rebound to 1.68 EPS for 2026 and 2.03 for 2027, so shareholders should watch whether margin recovery and volume trends can support that reset.
The pattern is net selling, but most of the recent activity is award-related and not a clean discretionary signal. The notable open-market action is Executive Chairman Albert Chao’s paired sales totaling 38,873 shares, which outweigh the automatic awards to directors and officers.
Profitability is still under pressure, with a 11.4% gross margin, 3.4% operating margin, and -3.9% net margin. Revenue growth is modest at 5.0% year over year, while EPS remains negative on a trailing basis at -3.47. Free cash flow was strong at $1.46 billion in 2025, but debt remains elevated at $6.41 billion versus $2.93 billion of cash.
WLK’s appeal is leverage to housing and infrastructure, but its margins trail stronger specialty chemical peers when pricing weakens. Valuation is not cheap on earnings, with a 90.7 P/E, though the market still prices it below the prior cycle peak.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.17B
- P/E
- -18.41
- Fwd P/E
- 41.56
- PEG
- 0.91
- P/S
- 0.71
- P/B
- 0.94
- EV/EBITDA
- 17.73
- Div Yield
- 3.32%
- Gross Margin
- 5.94%
- Op Margin
- -3.65%
- Net Margin
- -3.91%
- ROE
- -5.15%
- ROIC
- -1.77%
Latest fiscal year · YoY change
- Revenue
- $11.17B-8.0%
- Gross Profit
- $289.00M-85.2%
- Op Income
- $-1,578,000,000
- Net Income
- $-1,508,000,000-350.5%
- EPS
- $-11.73-351.7%
- OCF Growth
- -64.6%
- FCF Growth
- -273.2%
- 52W High
- $124.23
- 52W Low
- $56.33
- 50D MA
- $66.47
- 200D MA
- $86.16
- Beta
- 0.66
- RSI (14)
- 45
- Avg Volume
- 867.31K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Westlake beat last year on EBITDA and cash flow, helped by stronger PEM margins and pricing, but sequential results fell on lower chemical prices, higher Europe energy costs, and softer housing demand.· November 4, 2026
- Q3 EBITDA was $408 million and free cash flow was $220 million, both well above Q3 2025.
- PEM drove the year-over-year improvement: EBITDA rose to $215 million, with margin expanding to 11% from 5%.
- HIP was weaker: EBITDA fell to $195 million, with volume down 6% year over year excluding ACI and margin slipping to 18% from 20%.
- Management said its 3-pillar profitability plan has delivered $500 million of EBITDA uplift through the first 3 quarters and remains on track for $600 million of full-year earnings improvement.
- Westlake is pushing footprint optimization and cost control, including the Cologne PVC shutdown and broader HIP productivity actions, while keeping a strong balance sheet.
Westlake reported Q3 2026 sales of $3 billion and EBITDA of $408 million, versus EBITDA of $313 million in Q3 2025 and $679 million in Q2 2026. Free cash flow was $220 million, with $408 million of cash from operations and $188 million of capital expenditures. On a segment basis, HIP sales were $1.1 billion and EBITDA was $195 million, down $20 million year over year; PEM sales were $1.9 billion and EBITDA was $215 million, up $125 million year over year, with EBITDA margin improving to 11% from 5%. For Q4 2026, management guided HIP revenue to $900 million-$1 billion and an EBITDA margin of about 13%; company capex for 2026 is now expected to be $850 million, and cash interest expense is expected to be about $215 million.
Jean-Marc Gilson emphasized that Westlake is navigating an “unprecedented” chemical downturn by leaning on its North American feedstock advantage, cost actions, and footprint optimization. He pointed to $500 million of EBITDA uplift from the profitability plan year to date, the Cologne closure, and the move to concentrate European PVC volumes at Wilhelmshaven as steps to improve 2027 economics. His tone was cautious but constructive: he repeatedly stressed that macro conditions are fluid, but said the company is focused on creating its own tailwinds through cost, M&A, and innovation.
Jonathan Baksht highlighted the quarter’s financial bridge: about $200 million of the year-over-year EBITDA improvement came from the 3-pillar plan and about $100 million from higher PEM selling prices, partly offset by cost inflation, Europe energy, and lower HIP volume. He said Q3 operating cash flow was $408 million, capex was $188 million, and free cash flow was $220 million; cash and investments were $2 billion and total debt was $5.1 billion as of September 30. He also noted 2026 capex guidance was cut to $850 million, or about $150 million below last year, and said Q4 cash flow should benefit from a significant working-capital release.
Analysts focused on HIP cost inflation, including diesel, freight, and pricing pass-throughs; management said there is a lag before pricing catches up, and Q4 guidance assumes the current environment continues with limited near-term pricing relief. On Europe, management quantified a roughly $20 million Q3 cost headwind from European energy and said Q3 power costs were about €126 per megawatt hour versus €84 a year ago, with October around €170 and current prices above €200. Questions on polyethylene and ethane drew a more positive response: management said US PE demand and inventories look supportive, October and November price nominations are in play, and ethane costs may stay elevated but should be more than offset by higher PE prices and low gas costs.
The strongest bull case from the call is that Westlake’s PEM segment is showing real margin leverage: EBITDA more than doubled year over year, and management believes pricing, tighter inventories, and its advantaged US feedstock position can continue to support results. The company also appears to be executing on structural actions, with $500 million of EBITDA uplift already delivered under the profitability plan and additional benefits expected from Cologne/Wilhelmshaven and ongoing cost savings.
The main bear case is that end markets remain soft and volatile: HIP is facing weaker housing activity, higher mortgage rates, and some destocking, while PEM still sits below mid-cycle economics. Europe remains a major pressure point, with high energy costs and weak PVC profitability, and management said Q4 still includes lagged cost inflation in freight, diesel, and energy before any meaningful pricing relief may arrive.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 25.9%
- Shares Outstanding
- 127.89M
- Float Shares
- 33.11M
of shares held by institutions
368 13F filers
Buy/sell ratio 1.75. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for WLK, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Susie LeeHouse · NV03 | Sell | Jun 10, 21 | Filing → |
| Peter MeijerHouse · MI03 | Sell | Feb 16, 21 | Filing → |
| Susie LeeHouse · NV03 | Buy | Dec 16, 20 | Filing → |
| Susie LeeHouse · NV03 | Buy | Dec 10, 20 | Filing → |
| James ComerHouse · KY01 | Sell | Aug 6, 20 | Filing → |
| James ComerHouse · KY01 | Buy | Feb 24, 20 | Filing → |
| David Alfred PerdueSenate | Buy | Jan 15, 16 | Filing → |
| David Alfred PerdueSenate | Buy | Jan 29, 16 | Filing → |
| David Alfred PerdueSenate | Sell | Aug 14, 17 | Filing → |
| David Alfred PerdueSenate | Sell | Aug 10, 17 | Filing → |
| David Alfred PerdueSenate | Sell | Aug 9, 17 | Filing → |
| David Alfred PerdueSenate | Sell | Aug 8, 17 | Filing → |
| David Alfred PerdueSenate | Sell | Aug 4, 17 | Filing → |
| David Alfred PerdueSenate | Sell | Aug 3, 17 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 3.92M | ▲ 477.70K |
| Blackrock, Inc. | 3.29M | ▲ 215.07K |
| Capital World Investors | 2.84M | ▼ 1.37M |
| Dimensional Fund Advisors LP | 2.65M | ▲ 600.75K |
| Price T Rowe Associates Inc | 2.21M | ▼ 200.78K |
| Orbis Allan Gray Ltd | 2.08M | ▼ 3.21M |
| Vanguard Portfolio Management LLC | 1.75M | ▼ 17.18K |
| Brandes Investment Partners, LP | 1.57M | ▼ 269.71K |
| Aqr Capital Management LLC | 1.57M | ▲ 1.31M |
| Vanguard Capital Management LLC | 1.46M | ▲ 8.63K |
| State Street Corp | 1.45M | ▲ 72.91K |
| Goldman Sachs Group Inc | 1.28M | ▼ 112.45K |
Held by 471 ETFs
Biggest fund positions in WLK by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 31, 26 | Darby Tommy | other | 1,791 |
| Aug 31, 26 | Darby Tommy | other | 0 |
| Aug 14, 26 | Sheets Jeffrey Wayne | other | 2,184 |
| Aug 14, 26 | Sabat Carolyn Chao | other | 2,184 |
| Aug 14, 26 | Patel Bhavesh V. | other | 2,184 |
| Aug 14, 26 | NORTHCUTT R BRUCE | other | 2,184 |
| Aug 14, 26 | MCCOLLUM MARK A | other | 2,184 |
| Aug 14, 26 | Lubel Kimberly S | other | 2,184 |
| Aug 14, 26 | Graff Michael J | other | 2,184 |
| Aug 14, 26 | CREGG ROGER A | other | 2,184 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our WLK coverage
Recent articles, reports, and earnings notes.

Westlake Corporation (WLK): Recovery Story, But Still a Hold
Westlake is a Hold as cost-cutting and a 2026 earnings rebound could help, but weak Q1 results and uneven earnings execution keep the setup cautious.

Westlake (WLK): Cyclical Recovery Fueled by Cost Cuts
Westlake is a medium-term cyclical turnaround story with a resilient housing/infrastructure segment offsetting weak chemicals. Management’s 2026 EBITDA improvement plan and capacity rationalization support a constructive Buy view.

Westlake Corporation (WLK) falls 11% on weak Q1 results
Westlake Corporation (WLK) falls after-hours after a weak first quarter that missed on revenue and adjusted earnings. The selloff reflects slower recovery in its cyclical chemicals and building-products businesses, plus litigation and shutdown charges that pressured results and cloud the outlook for investors.
Want a deeper read on WLK?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Westlake Q3 Earnings Call Highlights
defenseworld.net · Nov 11
Westlake Q3 Earnings Call Highlights
marketbeat.com · Nov 8
Westlake (NYSE:WLK) & PPG Industries (NYSE:PPG) Head to Head Contrast
defenseworld.net · Nov 5
Westlake Corporation (WLK) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 4
Westlake (WLK) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
zacks.com · Nov 4
Westlake (WLK) Q3 Earnings and Revenues Lag Estimates
zacks.com · Nov 4
Westlake Chemical Partners LP Announces Third Quarter 2026 Results
globenewswire.com · Nov 4
Westlake Corporation Reports Third Quarter 2026 Results
globenewswire.com · Nov 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 9, 2026 · Live quote · Not investment advice